Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Journal of Clinical Lipidology|January 25, 2023
Adherence to statin treatment in patients with familial hypercholesterolemia: A dynamic prediction modelArjen J Cupido, Michel H Hof, Lotte M de Boer, et al.Obesity Surgery|November 21, 2019
Risk Factors for Cholecystectomy After Laparoscopic Roux-En-Y Gastric BypassSylke Haal, Djoeke Rondagh, Barbara A Hutten, et al.Blood|March 24, 2010
Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control studyBregje van Zaane, Alessandro Squizzato, Roeland Huijgen, et al.The Journal of Pediatrics|January 31, 2012
Follow-up of children diagnosed with familial hypercholesterolemia in a national genetic screening programHans J Avis, D Meeike Kusters, Maud N Vissers, et al.International Journal of Cardiology|September 11, 2014
Increased carotid intima-media thickness predicts cardiovascular events in aortic coarctationPaul Luijendijk, Huangling Lu, Frederike B Heynneman, et al.Journal of the American College of Cardiology|May 12, 2012
Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: a nested case-control studyRoeland Huijgen, S Matthijs Boekholdt, Benoit J Arsenault, et al.Circulation|March 9, 2011
Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic childrenAnouk van der Graaf, Hans J Avis, D Meeike Kusters, et al.European Heart Journal|March 13, 2012
Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemiaMohammad Mahdi Motazacker, James Pirruccello, Roeland Huijgen, et al.Atherosclerosis|September 20, 2011
Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation increases mortalityJorie Versmissen, Ilse P G Botden, Roeland Huijgen, et al.Clinical Therapeutics|May 4, 2010
Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trialRoeland Huijgen, Evertine J Abbink, Eric Bruckert, et al.Pageof 4